State MO
Clinical Trials in Missouri
Recruiting clinical trials with at least one study location in Missouri. Data updated daily from ClinicalTrials.gov.
Top Conditions in Missouri
NCT06418204 N/A
Recruiting
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients T...
Condition
Breast Carcinoma
Enrollment
2,000 pts
Location
United States, Puerto Rico
Sponsor
Wake Forest University Health
NCT07388264 N/A
Recruiting
Impact of Weizmannia (Bacillus) Coagulans JBI-YZ6.3 on Gut Health and Fecal Micr...
Condition
Gastrointestinal Symptoms
Enrollment
30 pts
Location
United States
Sponsor
Lindenwood University
NCT05939414 Phase 3
Recruiting
An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Obse...
Condition
Oligometastatic Prostate Cancer (OMPC)
Enrollment
450 pts
Location
United States, Argentina, Australia
Sponsor
Novartis Pharmaceuticals
NCT05362721 N/A
Recruiting
PV Loop & Coarctation Study
Condition
Coarctation of Aorta
Enrollment
20 pts
Location
United States
Sponsor
University of Minnesota
NCT04429087 Phase 1
Recruiting
A Study to Test Different Doses of BI 764532 in Patients With Small Cell Lung Ca...
Condition
Patients With Small Cell Lung Carcinoma and Other Neoplasms
Enrollment
300 pts
Location
United States, Germany, Japan
Sponsor
Boehringer Ingelheim
NCT05219799 EARLY_Phase 1
Recruiting
Sex Disparities in Hypoxic Vasodilation and Impact of Obesity
Condition
Obesity
Enrollment
72 pts
Location
United States
Sponsor
University of Missouri-Columbi
NCT06575192 Phase 3
Recruiting
Evaluation of the Safety and Effectiveness of ARTIA Reconstructive Tissue Matrix...
Condition
Breast Reconstruction
Enrollment
783 pts
Location
United States
Sponsor
AbbVie
NCT02402244 N/A
Recruiting
Project: Every Child for Younger Patients With Cancer
Condition
Adrenal Gland Pheochromocytoma
Enrollment
75,000 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
NCT07400588 Phase 2
Recruiting
Aleniglipron Phase 2 in Type 2 Diabetes Mellitus
Condition
Obese
Enrollment
50 pts
Location
United States
Sponsor
Gasherbrum Bio, Inc., a wholly
NCT05818683 Phase 1
Recruiting
A Study of JNJ-78278343 in Combination With Either JNJ-63723283 (Cetrelimab), Ta...
Condition
Metastatic Castration-resistant Prostate Neoplasms
Enrollment
277 pts
Location
United States, Australia, Spain
Sponsor
Janssen Research & Development
NCT05339139 Phase 3
Recruiting
SAfety of Regional Citrate Anticoagulation (SARCA Study)
Condition
Acute Kidney Injury
Enrollment
50 pts
Location
United States
Sponsor
Fresenius Medical Care North A
NCT05234567 N/A
Recruiting
A Prospective Sub-Study of the Global Hypophosphatasia Registry
Condition
Hypophosphatasia
Enrollment
30 pts
Location
United States
Sponsor
Alexion Pharmaceuticals, Inc.
NCT06533059 Phase 1
Recruiting
A Study to Learn About Study Medicine ALTA2618 in Adults With AKT1 E17K-Mutant S...
Condition
Cancer
Enrollment
110 pts
Location
United States, Australia, France
Sponsor
Alterome Therapeutics, Inc.
NCT07223853 N/A
Recruiting
AI-driven Clinical Decision Support for Perioperative Blood Orders
Condition
Surgery
Enrollment
50 pts
Location
United States
Sponsor
Washington University School o
NCT06106672 Phase 1, Phase 2
Recruiting
Evaluate the Safety, Tolerability, Pharmacodynamics and Efficacy of CNP-106 in S...
Condition
Myasthenia Gravis
Enrollment
54 pts
Location
United States
Sponsor
COUR Pharmaceutical Developmen
NCT07431853 Phase 2
Recruiting
A Study to Learn About mRNA Vaccines Against Influenza in Adults
Condition
Healthy Adults
Enrollment
770 pts
Location
United States
Sponsor
Pfizer
NCT06926634 Phase 2
Recruiting
Zanzalintinib Maintenance in Patients With High Grade Neuroendocrine Neoplasms (...
Condition
High Grade Neuroendocrine Neoplasms
Enrollment
32 pts
Location
United States
Sponsor
Washington University School o
NCT06799390 N/A
Recruiting
Auricular VNS Following Intracerebral Hemorrhage
Condition
Intracerebral Hemorrhage
Enrollment
80 pts
Location
United States
Sponsor
Washington University School o
NCT06513962 Phase 3
Recruiting
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults...
Condition
Hematopoietic and Lymphatic System Neoplasm
Enrollment
60 pts
Location
United States, Canada
Sponsor
Children's Oncology Group
NCT07284186 Phase 1
Recruiting
First-in-Human Study of PLX-61639 in Locally Advanced or Metastatic Solid Tumors
Condition
Esophageal Squamous Cell Carcinoma
Enrollment
155 pts
Location
United States
Sponsor
Plexium, Inc.
NCT06307652 Phase 3
Recruiting
Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With Hear...
Condition
Heart Failure and Impaired Kidney Function
Enrollment
4,800 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT00574327 N/A
Recruiting
Progression of Gastroesophageal Reflux Disease and Barrett's Esophagus and the C...
Condition
Barrett's Esophagus
Enrollment
3,000 pts
Location
United States
Sponsor
Midwest Biomedical Research Fo
NCT03988283 Phase 1
Recruiting
Neoepitope-based Personalized DNA Vaccine Approach in Pediatric Patients With Re...
Condition
Pediatric Recurrent Central Nervous System Tumors
Enrollment
7 pts
Location
United States
Sponsor
Washington University School o
NCT05301413 Phase 2
Recruiting
Social Determinants and a Diabetes Prevention Program Tailored for African Ameri...
Condition
PreDiabetes
Enrollment
360 pts
Location
United States
Sponsor
University of Missouri, Kansas
NCT07266558 Phase 4
Recruiting
A Study to Evaluate the Efficacy and Safety of mRNA-1283 and mRNA-1273 in Partic...
Condition
SARS-CoV-2
Enrollment
30,000 pts
Location
United States
Sponsor
ModernaTX, Inc.
Page 1 of 11 — 255 trials total